Trials / Completed
CompletedNCT05961137
Orange Park Out-of-Hospital Quality Improvement Study for Improving CMS Sepsis Core Measures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Orange Park Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this quality improvement study is to measure the impact of incorporation of a manual rapid fluid infuser (RFI) for intravenous crystalloid infusion in patients with suspected sepsis in the prehospital interval. The main question\[s\] it aims to answer are: * Does the intervention affect the timeliness of fluid administration? * Does the intervention affect CMS sepsis bundle care measure compliance? * Does the intervention affect processes and outcomes of care? * Are there any adverse effects? Researchers will compare this intervention to use of more conventional gravity or pressure-infusion bag crystalloid infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol | Modified protocol specifying intravenous crystalloid infusion Rapid Fluid Infusion Device. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids. |
| OTHER | Conventional Prehospital Suspected Sepsis Protocol | Conventional protocol employing intravenous crystalloid infusion via gravity or pressurized-bag. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-12-31
- Completion
- 2022-08-31
- First posted
- 2023-07-27
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05961137. Inclusion in this directory is not an endorsement.